The last 20 actions on file set price targets from $23.00 to $38.00, averaging $32.12.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 7 Oct 2026 | Truist Financial | BUY | $31.00 |
| 5 Oct 2026 | Needham | BUY | $33.00 |
| 23 Sep 2026 | Oppenheimer | BUY | $32.00 |
| 21 Sep 2026 | Truist Financial | BUY | – |
| 9 Sep 2026 | Leerink Partners | HOLD | $28.00 |
| 24 Aug 2026 | Truist Financial | BUY | – |
| 17 Aug 2026 | Barclays | HOLD | $25.00 |
| 10 Aug 2026 | J.P. Morgan | SELL | $23.00 |
| 5 Aug 2026 | Needham | BUY | $33.00 |
| 5 Aug 2026 | H.C. Wainwright | BUY | $38.00 |
| 27 Jul 2026 | Needham | BUY | $32.00 |
| 1 Jul 2026 | H.C. Wainwright | BUY | $38.00 |
| 30 Jun 2026 | Needham | BUY | $32.00 |
| 14 May 2026 | Barclays | HOLD | $25.00 |
| 4 May 2026 | H.C. Wainwright | BUY | $38.00 |
| 1 May 2026 | Truist Financial | BUY | – |
| 1 May 2026 | Needham | BUY | $32.00 |
| 1 May 2026 | H.C. Wainwright | BUY | $38.00 |
| 20 Apr 2026 | H.C. Wainwright | BUY | $38.00 |
| 16 Apr 2026 | Needham | BUY | $30.00 |
No comments yet — be the first to weigh in on PCRX.